PECAM1 and neoplasm: The CD31 IHC staining and Masson’s staining results also showed that the combined treatment of PTC-209 and Bevacizumab can effectively inhibit tumor angiogenesis, and its efficacy is better than single drug treatment (Fig. 6E and Supplementary Fig. 9).